Hanover, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Sickle Cell Disease Association of America Inc, founded in 1972, is a community nonprofit that reported $1.1M in total revenue in fiscal year 2022. Revenue fell 68% from the prior year — a significant decline worth monitoring. Expenses of $1.3M exceeded revenue, resulting in a 22% operating deficit.
To advocate for people affected by sickle cell conditions and empower community-based organizations.
HRSA: To provide a newborn screening follow-up program that ensures access to care for individuals with sickle cell disease (SCD). It includes providing follow-up services: Education, counseling...
HRSA: To provide a newborn screening follow-up program that ensures access to care for individuals with sickle cell disease (SCD). It includes providing follow-up services: Education, counseling, lead advocacy initiatives, and access to medical home.
SCDAA: SCDAA and its member organizations engage in community outreach and program efforts throughout the United States and Canada. These efforts include but not limited to: Educational campaigns...
SCDAA: SCDAA and its member organizations engage in community outreach and program efforts throughout the United States and Canada. These efforts include but not limited to: Educational campaigns that build awareness of SCD and related conditions and programs that provide services such as genetic testing and counseling, case management, and psychosocial support for individuals and families impacted by sickle cell disease.
PCORI: To develop a national advocate network of sickle cell disease patients, families, caregivers and other stakeholders experts that can partner with clinicians and researchers to design...
PCORI: To develop a national advocate network of sickle cell disease patients, families, caregivers and other stakeholders experts that can partner with clinicians and researchers to design, implement and eventually disseminate patient centered outcomes research and comparative effectiveness research (PCOR/CER) projects that improve outcomes to patients with sickle cell disease (SCD).
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $1,104,795 | $3,493,721 | -0.7% |
| Expenses | $1,342,644 | $2,806,839 | -0.5% |
| Net Income | $-237,849 | $686,882 | -1.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| David N Braxton Phd | Chair | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Ed Folwers | Treasurer | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jakela Parker | Vice Chair | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Genice T Nelson DNP APRN | Secretary | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Biree Andemarian MD | Chief Medical Officer | 5.00 |
Director
|
$0 | $0 | $0 |
| Lewis Hsu MD | Vice Chief Medical Officer | 5.00 |
Director
|
$0 | $0 | $0 |
| Lennette J Benjamin MD | Board Member Emeritus | 5.00 |
Director
|
$0 | $0 | $0 |
| Kim Smith-Whitley MD | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Regina Hartfield | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Christopher Hollins MBA | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Wanda Whitten-Shurney MD | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Crystal A Riley MHA MBA | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Bernie Lawrence-Watkins | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Gwendolyn PolesDO | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Thomas L Johnson JD | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Tanique Mitchell | Member | 5.00 |
Director
|
$0 | $0 | $0 |
| Beverley Francis-Gibson | President/CEO | 45.00 |
Officer
|
$0 | $0 | $0 |
| Leroy Hughes | Vice President | 45.00 |
Key Emp
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | No data | No data | No data | No data |
| 2022 | $1,104,795 | $1,342,644 | $1,952,170 | $-237,849 |
| 2021 | $3,493,721 | $2,806,839 | $2,467,677 | $686,882 |
| 2021 | $3,390,902 | $3,024,558 | $2,360,469 | $366,344 |
| 2020 | $5,839,599 | $5,030,834 | $2,209,830 | $808,765 |
| 2019 | $4,314,746 | $4,208,906 | $1,399,367 | $105,840 |
| 2018 | $4,227,112 | $3,984,238 | $1,315,287 | $242,874 |
Compare Sickle Cell Disease Association of America Inc with other nonprofits in Maryland and across the country.